New listings
LB PharmaceuticalsLBRX
ListedNasdaq
Road to listing
- Filed (S-1)25/08/22
- 1 amendment25/09/08Last amendment
- Declared effective25/09/10
- Priced25/09/10
- Listed25/09/11
- Lock-up ends03/10Passed
Offering terms
- Offer price
- $15.00
- Shares offered
- 19,000,000 sh
- Raised
- $285M
- Exchange
- Nasdaq
- Lock-up
- 180 days · prospectus
LB Pharmaceuticals stock pagePrice and every trade
5% holders
| Form | ||||
|---|---|---|---|---|
| 11.7% | 3,352,804 sh | 13D | 02/10 | |
| 8.7% | 2,208,604 sh | 13G passive | 02/17 | |
| 6.8% | 1,972,369 sh | 13G passive | 05/15 | |
| 6.3% | 1,411,681 sh | 13D | 25/09/25 | |
| 6.3% | 1,796,543 sh | 13G passive | 07/29 | |
| 5.2% | 1,497,293 sh | 13G passive | 07/16 | |
| 5.0% | 1,438,070 sh | 13G passive | 05/15 | |
| 5.0% | 1,447,310 sh | 13G passive | 08/14 | |
| 5.0% | 1,268,265 sh | 13G passive | 25/12/31 | |
| 3.8% | 961,158 sh | 13G passive | 01/21 |
1 planned sale notice (Form 144) by this company's insiders
Filings
- EFFECT notice of effectiveness04/14
- S-1 registration statement04/06
- 424B4 final prospectus25/09/12
- EFFECT notice of effectiveness25/09/10
- 8-A12B exchange registration25/09/09
- S-1/A amendment25/09/08
- S-1 registration statement25/08/22